Hyperglycemia does not alter state 3 respiration in cardiac mitochondria from type-I diabetic rats

Ossama Lashin1, Andrea Romani

  • 1Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH, USA.

Insights

Diabetic rats show reduced heart mitochondrial function, but this is linked to insulin levels, not just high blood sugar. This suggests insulin deficiency, not hyperglycemia, drives diabetic cardiomyopathy.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Mitochondrial Biology

Background:

  • Cardiovascular complications are the leading cause of death in diabetic patients.
  • Diabetic cardiomyopathy, a form of heart dysfunction, is a major diabetes complication.
  • Mitochondria are implicated in cardiac dysfunction, but mechanisms remain unclear.

Purpose of the Study:

  • To investigate the role of hyperglycemia versus insulin levels in diabetic heart mitochondrial dysfunction.
  • To determine the impact of diabetes on mitochondrial respiration in rat hearts.

Main Methods:

  • Induction of type-I diabetes in Sprague-Dawley rats using streptozotocin.
  • Measurement of mitochondrial state 3 (oxygen consumption) and state 4 respiration.
  • Comparison of mitochondrial function between diabetic, hyperglycemic non-ketotic, and control rats.

Main Results:

  • Diabetic rat hearts showed a 35% reduction in state 3 oxygen consumption by week 4.
  • Hyperglycemic non-ketotic rats, despite similar blood sugar, had normal state 3 respiration.
  • Diabetic mitochondria exhibited increased state 4 respiration with glutamate and succinate, unlike controls.

Conclusions:

  • Hyperglycemia alone does not directly cause the decline in state 3 oxygen consumption in diabetic rat cardiac mitochondria.
  • Lower insulin levels and associated metabolic changes appear to be the primary drivers of mitochondrial dysfunction in type-I diabetes.
  • Findings suggest a novel mechanism for diabetic cardiomyopathy linked to insulin deficiency and mitochondrial impairment.

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...